| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.09 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |